Adakveo (crizanlizumab-tmca) - Novartis
Brain MRI and cognitive outcomes in adults with sickle cell disease treated with crizanlizumab. (PubMed, Blood Red Cells Iron) - Oct 7, 2026 - No abstract available 
Journal • Genetic Disorders • Hematological Disorders • Sickle Cell Disease
http://www.ncbi.nlm.nih.gov/pubmed/42835727
 
Allison A King; Andria L Ford; Hongyu An; Kristina Rankine; Lauren Brewer; Martin N Reis; Morey Blinder; Serguei Astafiev; Sheng-Kwei Song; Slim Fellah; Yan Wang; Yasheng Chen
 
Oct 7, 2026
 
Prev Next